Tony Gibney ^Investor

Experienced Chief Financial Officer and Independent Director with a background in biotechnology investment banking. Led successful strategic processes resulting in significant shareholder value creation through M&A transactions. Skilled in financial advisory and new indications efforts for complement inhibition platforms. Strong track record of raising capital and driving company growth. Proven ability to maximize asset value and build comprehensive ophthalmic powerhouses. Adept at working directly in the biotech industry to advance innovative treatments for autoimmune and retinal diseases. (63 words)